Ionic and Enzymatic Multiple-Crosslinked Nanogels for Drug Delivery
School of Chemistry and Materials Science, Ludong University, Yantai 264025, China
*
Author to whom correspondence should be addressed.
Polymers 2021, 13(20), 3565; https://doi.org/10.3390/polym13203565
Submission received: 22 September 2021
/
Revised: 8 October 2021
/
Accepted: 13 October 2021
/
Published: 15 October 2021
(This article belongs to the Special Issue Advances in Natural or Synthetic Biomaterials for Developing Micro or Nano Drug Delivery Systems)
Abstract
:Both ionic and enzymatic crosslink are efficient strategies for constructing network materials of high biocompatibility. Here chitosan was modified firstly and then crosslinked by these two methods for complementary advantages. The preparation methods and ionic crosslinkers can regulate the size and uniformity of the multiple-crosslinked nanogels. The multiple-crosslinked nanogels with the smallest size and the best uniformity was selected for the drug delivery. The drug-loading content and encapsulation efficiency were up to 35.01 and 66.82%, respectively. Their release behaviours are correlated with the pH value and the drug dosage. In general, the lower pH value and the lower drug dosage promoted the drug release. With the assistance of several kinetic models, it is found that drug diffusion plays a preponderant role in drug release, while polymer relaxation has a subtle effect. The multiple-crosslink resulting from ionic compounds and enzymes may provide a new perspective on developing novel biocompatible materials.
1. Introduction
Natural polymeric materials are popular candidates for drug carriers due to their excellent biocompatibility and biodegradability. Many strategies have been devised to endow the drug carriers based on natural polymeric materials with extensive and advanced functions [1,2,3]. The stable and compact structures composed of natural polymers are generally desired. Various kinds of crosslinkers play vital roles in building these structures [4,5]. The chemical crosslinking reagents (e.g., dialdehyde) were introduced early and performed satisfactorily. However, the possible cytotoxicity [6] and strong covalent bonding brought by chemical crosslinkers impair the biocompatibility and biodegradability of natural polymeric materials. More attention has been paid to bio-friendly crosslinkers, such as ionic crosslinkers and enzymatic crosslinkers.
Ionic crosslinking is a mild reaction that is suitable for natural polymers [7,8,9]. Chitosan becomes a polycationic polymer in a solution of a pH value less than 6. Thus it can be crosslinked by the anionic reagent, such as divalent sulphate (SO42−), trivalent phosphate (PO43−), and pentavalent tripolyphosphate (TPP). Ionic crosslinked materials often exhibit excellent biocompatibility and pH sensitivity, making them qualified for drug carriers [10]. The enzyme can catalyze the crosslinking of natural polymers efficiently. The amino acid residues on the gelatin chains are crosslinked rapidly with the catalysis of microbial transglutaminase (mTG) [11,12,13]. The phenol groups grafted on the natural polymers can be crosslinked in the presence of horseradish peroxidase (HRP) and H2O2 [14,15,16]. The enzymatic reactions occur fast and gently under the physiological environment. More significantly, the biocompatibility of enzymes is beyond doubt [17,18].
However, the ionic crosslinked materials are hard to retain stable structures, and enzymatic crosslinked materials may degrade quickly. It is realized that the combined utilization may complement crosslinking methods for each other and obtain a material with optimized properties. The combinations of crosslinking methods have been reported in the studies of tissue engineering scaffolds [19,20]. For example, the interpenetrating polymer network (IPN) materials are composed of two different polymers crosslinked by two different methods [21]. The IPN hydrogels prepared by Lee et al. were composed of chitosan and poly (acrylic acid) [22]. The IPN hydrogels reported by Li et al. were composed of gelatin and alginate [23].
Nevertheless, one polymer multiple-crosslinked by several methods is more favourable as drug carriers with nanoscales because of the easier preparation and more controllable delicate structures. Here we crosslinked the same polymer by ionic and enzymatic crosslinkers coordinately to prepare nanogels whose structures were easily regulated. Their performances in a drug delivery were studied furthermore. The novel multiple crosslinking is expected to bring a new perspective for the drug carriers with natural polymer.
2. Materials and Methods
2.1. Materials and Instruments
Chitosan (the deacetylation degree ≥ 95%), 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC-HCl), N-hydroxysuccinimide (NHS), Phloretic acid (PA), 2-(N-Morpholino)ethanesulfonic acid (MES), Sodium tripolyphosphate (TPP), and Sodium molybdate (Na2MoO4) and horseradish peroxidase (HRP) (>300 U/mg, lyophilized powder) were all purchased from Aladdin Biochemical Technology Co., Ltd. (Shanghai, China) and used as received. 5-Fluorouracil (5-FU) was obtained from Macklin Biochemical Co., Ltd. (Shanghai, China). Nuclear magnetic resonance (NMR) spectrometer (AVANCE NEO, 500 MHz, Bruker) and Fourier transform infrared (FTIR, MAGNA550, Nicolet) was used for structural analysis. Nanoparticle size analyzer (Nano-ZS90, Malvern) was used to determine the size of the nanogels. UV-Vis spectrophotometer (T6, Persee) was used to determine the concentrations of 5-FU in the drug loading and release experiments.
2.2. Synthesis of Phenolic Hydroxyl Modified Chitosan (MC)
The phenolic hydroxyl group was conjugated to the amine group of chitosan in the presence of EDC/NHS. 1.28 g of chitosan was dissolved in 100 mL of a 0.5% acetic acid solution [24,25,26]. The pH value was adjusted to approximately 5.0 after complete dissolution. PA of 0.88 g, 0.93 g of NHS, and 1.52 g of EDC-HCl were dissolved in a 100 mL mixture of N, N-dimethylformamide (DMF) and deionized water (v/v = 3:2). Then it was blended with a chitosan-acetic acid solution and kept at ambient temperature for 20 h. The reaction mixture was dialyzed against deionized water for several days and then freeze-dried to obtain the modified chitosan (MC). 1H NMR spectrum of MC in D2O was recorded at 500 MHz. FTIR spectra of MC and chitosan were recorded in the wavenumber range of 4000–400 cm−1 using KBr pressed disk technique.
2.3. Preparation of Nanogels with TPP and HRP Multiple-Crosslinking
The MC was dissolved in MES solutions for at least 24 h, and the pH values were kept at 5.0. TPP and HRP were respectively dissolved at specific concentrations in advance. Then the chitosan nanogels were prepared according to the composition listed in Table 1. Besides the different TPP concentrations, different preparation methods were also employed. One method was adding the MC solution into the TPP solution first and then mixing it with the HRP and H2O2 solution. The other method was adding the MC solution into the TPP, HRP, and H2O2 mixed solution. All the solution mixing and the preparations of the nanogels were performed with mild electromagnetic stirring and stabilized at room temperature for 24 h.
2.4. Preparation of Nanogels with Na2MoO4 and HRP Multiple Crosslinking
The nanogels with Na2MoO4 and HRP were prepared according to the method above, and their composition was listed in Table 2.
2.5. Measurement of the Nanogel Size
The nanogel size was determined by a nanoparticle size analyzer with the appropriate dilution. Measurements of all the samples were repeated 3 times, and the hydrodynamic diameter distribution was recorded based on the scattered light intensity.
2.6. Drug Loading
5-FU was dissolved in MES solutions and subsequently mixed with the MC solution. The mass ratio of 5-FU to MC was 50, 100 and 150%, respectively. These mixtures were used to prepare drug-loaded nanogels, referring to the method above. The solutions of nanogels were dialyzed against deionized water for 3 h. Then the concentrations of 5-FU in dialysates were determined by UV-Vis spectrophotometer. The standard solutions of 5-FU were prepared in the concentrations of 2.5 mg/L, 5 mg/L, 7.5 mg/L, 10 mg/L, 12.5 mg/L, respectively. The UV-Vis spectra of 5-FU solutions showed the highest absorption peak at 265 nm, which was selected as the measuring wavelength to determine the standard curve of 5-FU. The standard calibration was repeated 3 times, and the R2 of the standard curve were all more than 0.99. The drug-loading content (DLC%) and entrapment efficiency (EE%) of the nanogels were calculated according to the reference [27].
2.7. Drug Release
The drug release in vitro was studied by UV-Vis spectrophotometer. The drug-loaded nanogels (5 mL) were dialyzed against 50 mL of MES solutions at 25 °C. The pH value of the MES solution was adjusted in advance to 5.5, 6.5 or 7.5 by adding hydrochloric acid or potassium hydroxide. A 3 mL portion of the dialysate was extracted at predetermined intervals to determine the concentration of the drug. At the same time, 3 mL of fresh MES solution was added to the dialysate. The experiments were performed in triplicate, and the results were expressed in terms of the cumulative drug release [28].
The kinetics of the 5-FU released from the nanogels was determined by fitting the release profiles to several theoretical models (including zero-order, first-order, Higuchi, Korsmeyer-Peppas, and Peppas-Sahlin models).
3. Results and Discussion
3.1. Structural Characterization and Enzymatic Crosslinking of MC
The 1H NMR spectrum of MC (Supplementary Materials Figure S1) showed the chemical shifts of both PA groups and chitosan, proving that the phenolic hydroxyl was grafted on the chitosan. The chemical shifts at 6.76 and 6.44 ppm corresponded to the aromatic protons of the phenolic group. The chemical shifts at 2.44 and 2.27 ppm corresponded to the methylene protons of PA. The chemical shifts from 4.51 to 2.80 ppm corresponded to the glucopyranose ring protons of chitosan. FTIR was also used to confirm the chemical structure (Figure S2). In the FTIR spectrum of chitosan, the bands at 3354 cm−1 (stretching vibrations of –OH and –NH2 in chitosan), at 1150 cm−1 (asymmetric stretching vibration of C–O–C bridge between glucopyranose rings), at 1024 cm−1 (stretching vibrations of glucopyranose ring) were observed. The FTIR spectrum of MC exhibited the bands attributing to the stretching vibration of –OH in the phenolic group (3257 cm−1), asymmetric stretching vibration of C–H in the methylene of PA (2920 cm−1), and stretching vibration of C–C in the phenolic group (1644–1514 cm−1).
The crosslinking of the MC under the enzymatic catalysis was verified. The MC solution was low-viscous and flowable before adding HRP, whereas the gel was formed soon after adding HRP (Figure 1). It proves that the phenolic hydroxyl groups were grafted with the chitosan chains, which linked to each other in the presence of HRP. Thus, a three-dimensional network was constructed. This enzymatic crosslinking was in line with expectations and ready for the preparation of multiple-crosslinked nanogels.
3.2. Influences on the Preparations of Multiple-Crosslinked Nanogels
Two methods were used to prepare the multiple-crosslinked nanogels, where the crosslinking occurred with the ionic crosslinker first and then with HRP (method A) or the crosslinking occurs with the ionic crosslinker and HRP simultaneously (method B). Besides, the nanogels prepared only with ionic crosslinkers were compared with them (Figure 2).
The different hydrodynamic diameters of the nanogels indicate that the HRP-involved nanogel generally has a smaller size because the extra crosslinking provided by HRP makes the chitosan networks more compact. Further comparing methods A and B shows that the nanogels prepared by method B were smaller than those prepared by method A. it is considered that the crosslinking of chitosan chains is more efficient when two types of crosslinkers coexist. It is tricky for HRP to catalyze in method A because the ionic crosslinking occurs first, making a part of the phenolic hydroxyl groups wrapped inside.
In addition to the method, the type of ionic crosslinker also significantly impacts the preparation of multiple-crosslinked nanogels. The multiple-crosslinked nanogels prepared with Na2MoO4 have a smaller size and narrower distribution, which is more competitive for drug delivery. The crosslinking efficiency depends on the ionic bonds between anions of the crosslinker and amino ions of the chitosan. TPP exists as a pentavalent anion, and Na2MoO4 exists as a divalent anion in solutions. TPP possesses more joinpoints than Na2MoO4 with the same mass. Hence more chitosan chains were linked with TPP rather than Na2MoO4, causing the larger nanogels.
Moreover, the concentrations of ionic crosslinkers have an apparent effect on the size of the multiple-crosslinked nanogels. The sizes of the nanogels decrease as the ion concentration decreases, shown in both methods A and B (Figure 3). The higher ion concentration provides more crosslinking points and thus increases the possibility of forming larger crosslinking structures. It is noted that the nanogels prepared by method B were all smaller than those prepared by method A in the case of four different concentrations.
Considering the above influences, the multiple-crosslinked nanogel labelled as MC/M/H-B4 was selected for the subsequent drug delivery experiments due to its smallest size and the best uniformity among all the samples.
3.3. Drug Loading in Multiple-Crosslinked Nanogels
In the drug delivery experiments, 5-FU was selected as a model drug. 5-FU is a common anti-metabolism and anti-tumour drug, but it usually causes gastrointestinal discomfort when taken directly. Therefore, a sustained-release carrier is necessary to improve drug utilization and reduce the damage to healthy cells.
The drug-loading method determined by screening tests is to mix 5-FU firstly with MC rather than with crosslinkers. This method is feasible because the 5-FU could be dispersed evenly among the complex spatial conformation of chitosan longer chains, improving the loading efficiency of 5-FU in the network structures of nanogels (Figure 4a).
The size and uniformity of the drug-loaded nanogels are necessary for the long-term circulation of drug carriers in the body. Here the influence of different drug dosages was studied (Figure 4b). With the increase of drug dosage from 50 to 150%, the hydrodynamic diameters of 5-FU loaded nanogels increase, and the size distributions become wide.
The essential criteria for drug-loading experiments are drug-loading content (DLC) and entrapment efficiency (EE), listed in Table 3. The DLC increased from 23.55 to 35.01% with the drug dosage increase. However, the increase gets small when the dosage increases from 100 to 150%. It is indicated that increasing the drug dosage would not be worthwhile because the DLC almost reached the maximum amount that the nanogels could withstand. The EE decreased with the drug dosage increase and reached 66.82% when the drug dosage was 50%. Overall, increasing the drug dosage could achieve a higher DLC, but more 5-FU cannot be loaded in the carrier, resulting in a waste of drugs. The balance between the DLC and EE should be determined on the requirements of specific applications.
3.4. Drug Release from Multiple-Crosslinked Nanogels
Chitosan shows pH sensitivity due to the amino groups. Consequently, the release profiles of chitosan-derived drug carriers are generally impacted by the pH values. The influences of pH on drug release behaviours from MC/M/H-B4 nanogels were studied (Figure 5).
The 5-FU release was slow in the first 30 h at pH 7.5, and the maximum cumulative release was 38.7% (dosage of 50%). The 5-FU duration increased to 48 h at pH 6.5, and the maximum cumulative release was 60.8% (dosage of 50%). The fastest 5-FU release occurred at pH 5.5, and the maximum cumulative release was 71.2% (dosage of 50%). It shows that the drug could be released from the MC/M/H-B4 nanogels and be easier to leave at lower pH values. As the pH value decreases, the drug release becomes faster, and the maximum cumulative release increases.
The reasons for the pH-responsive release were analyzed. The protonated chitosan chains are more stretched and bring looser networks, causing faster drug release at a lower pH. However, 5-FU was also protonated in the acid medium and competed with chitosan. It is difficult for chitosan chains to maintain the loose structure when the 5-FU concentration increases. Therefore the two higher dosages groups’ release at pH 5.5 slowed down significantly after 20 h.
It is also found that the drug release becomes quicker, and the maximum cumulative release increases with the drug dosage decrease at the three different pH levels. (Figure 5d). The path of drug diffusion is complicated due to the network structure. Thus the drug molecules are more difficult to arrive outside when the drug-loading content is higher.
Furthermore, several kinetic models were used to evaluate the drug release profiles for revealing the mechanism of drug release. The equations and parameters of the different models are listed in Table 4 [29,30,31]. The R2 of Korsmeyer-Peppas and Peppas-Sahlin are higher than zero-order, first-order and Higuchi, indicating that Korsmeyer-Peppas and Peppas-Sahlin are adequate for describing the release behaviours.
The diffusional release exponent (n) of the Korsmeyer-Peppas model reveals the mechanism of drug release from porous hydrophilic polymers and is effective when the released drug is no more than 60%. Moreover, the K2 of the Peppas-Sahlin model represents the polymer relaxation’s contribution to the drug release with no restriction on the drug release [32]. Therefore, a combination of these two models is optimal to analyze the chitosan-derived nanogels.
The n values for the 100 and 150% dosage are less than 0.45, indicating that these release mechanisms are Fickian diffusion. The n values for a dosage of 50% are more than 0.45 and less than 0.89, indicating a case II transport (erosion-controlled drug release) [33]. The n values increase with pH decrease. It is considered that the hydrogen bonds between the chitosan and 5-FU are formed. The proportion of 5-FU that forms hydrogen bonds is more prominent with less dosage, and the lower pH is conducive to hydrogen bonding.
K1 and K2 of Peppas-Sahlin models respectively represent drug diffusion and polymer relaxation contributions to the drug release [34]. For all release profiles of 5-FU release from MC/M/H-B4 nanogels, drug diffusion plays a preponderant role in the drug release rate, while polymer relaxation has a subtle effect on the release rate.
4. Conclusions
The ionic (TPP or Na2MoO4) and enzymatic (HRP) crosslinkers were employed to prepare the multiple-crosslinked chitosan nanogels. The size and uniformity of the multiple-crosslinked nanogels are influenced by preparation methods and types and concentrations of the ionic crosslinker. The multiple-crosslinked nanogels of small size and high uniformity were selected for the drug delivery. The multiple-crosslinked chitosan nanogels perform impressively on drug loading and controlled release. The drug-loading content and encapsulation efficiency are up to 35.01 and 66.82%, respectively. Adjusting the pH value and the drug dosage could change the release rate and the maximum cumulative release from the multiple-crosslinked nanogels. Moreover, the evaluation of kinetic models explains the release mechanism under different conditions.
The ionic and enzymatic multiple-crosslinked nanogels positively impact biocompatibility and work well as drug carriers. The method developed in this study could provide new opportunities for biomedical applications of natural polymers.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/polym13203565/s1, Figure S1: 1H NMR spectrum of MC in D2O at 500 MHz, Figure S2. FTIR spectra of chitosan and MC.
Author Contributions
Conceptualization, Q.T.; methodology, J.Z. and Q.T.; sample preparation, data collection and analysis, J.Z. and R.W.; writing—original draft preparation, R.W. and Y.H.; writing—review and editing, Q.T.; project administration, Q.T. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the National Natural Science Foundation of China (Grant No. 51403096) and the Natural Science Foundation of Shandong, China (Grant No. ZR2014EMP003).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data is contained within the article.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Wang, W.; Liu, X.; Xie, Y.; Zhang, H.; Yu, W.; Xiong, Y.; Xie, W.; Ma, X. Microencapsulation using natural polysaccharides for drug delivery and cell implantation. J. Mater. Chem. 2006, 16, 3252. [Google Scholar] [CrossRef]
- Nigmatullin, R.; Thomas, P.; Lukasiewicz, B.; Puthussery, H.; Roy, I. Polyhydroxyalkanoates, a family of natural polymers, and their applications in drug delivery. J. Chem. Technol. Biotechnol. 2015, 90, 1209–1221. [Google Scholar] [CrossRef]
- Tong, X.; Pan, W.; Su, T.; Zhang, M.; Dong, W.; Qi, X. Recent advances in natural polymer-based drug delivery systems. React. Funct. Polym. 2020, 148, 104501. [Google Scholar] [CrossRef]
- Luo, K.; Yang, Y.; Shao, Z. Physically crosslinked biocompatible silk-fibroin-based hydrogels with high mechanical performance. Adv. Funct. Mater. 2016, 26, 872–880. [Google Scholar] [CrossRef]
- Liu, Y.; Zheng Shu, X.; Prestwich, G.D. Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials 2005, 26, 4737–4746. [Google Scholar] [CrossRef] [PubMed]
- Berger, J.; Reist, M.; Mayer, J.M.; Felt, O.; Peppas, N.A.; Gurny, R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57, 19–34. [Google Scholar] [CrossRef]
- Gierszewska, M.; Ostrowska-Czubenko, J. Chitosan-based membranes with different ionic crosslinking density for pharmaceutical and industrial applications. Carbohydr. Polym. 2016, 153, 501–511. [Google Scholar] [CrossRef] [PubMed]
- Liling, G.; Di, Z.; Jiachao, X.; Xin, G.; Xiaoting, F.; Qing, Z. Effects of ionic crosslinking on physical and mechanical properties of alginate mulching films. Carbohydr. Polym. 2016, 136, 259–265. [Google Scholar] [CrossRef]
- Kuo, C.K.; Ma, P.X. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials 2001, 22, 511–521. [Google Scholar] [CrossRef]
- Izzo, D.; Palazzo, B.; Scalera, F.; Gullotta, F.; lapesa, V.; Scialla, S.; Sannino, A.; Gervaso, F. Chitosan scaffolds for cartilage regeneration: Influence of different ionic crosslinkers on biomaterial properties. Int. J. Polym. Mater. Polym. Biomater. 2019, 68, 936–945. [Google Scholar] [CrossRef]
- Gupta, D.; Santoso, J.W.; McCain, M.L. Characterization of gelatin hydrogels cross-linked with microbial transglutaminase as engineered skeletal muscle substrates. Bioengineering 2021, 8, 6. [Google Scholar] [CrossRef]
- Chen, R.-N.; Ho, H.-O.; Sheu, M.-T. Characterization of collagen matrices crosslinked using microbial transglutaminase. Biomaterials 2005, 26, 4229–4235. [Google Scholar] [CrossRef] [PubMed]
- McDermott, M.K.; Chen, T.; Williams, C.M.; Markley, K.M.; Payne, G.F. Mechanical properties of biomimetic tissue adhesive based on the microbial transglutaminase-catalyzed crosslinking of gelatin. Biomacromolecules 2004, 5, 1270–1279. [Google Scholar] [CrossRef]
- Roberts, J.J.; Naudiyal, P.; Lim, K.S.; Poole-Warren, L.A.; Martens, P.J. A comparative study of enzyme initiators for crosslinking phenol-functionalized hydrogels for cell encapsulation. Biomater. Res. 2016, 20, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, F.; Bae, K.H.; Kurisawa, M. Injectable hydrogel systems crosslinked by horseradish peroxidase. Biomed. Mater. 2015, 11, 14101. [Google Scholar] [CrossRef]
- Kurisawa, M.; Chung, J.E.; Yang, Y.Y.; Gao, S.J.; Uyama, H. Injectable biodegradable hydrogels composed of hyaluronic acid–tyramine conjugates for drug delivery and tissue engineering. Chem. Commun. 2005, 4312. [Google Scholar] [CrossRef]
- Zhang, Y.; Fan, Z.; Xu, C.; Fang, S.; Liu, X.; Li, X. Tough biohydrogels with interpenetrating network structure by bienzymatic crosslinking approach. Eur. Polym. J. 2015, 72, 717–725. [Google Scholar] [CrossRef]
- Fan, Z.; Zhang, Y.; Fang, S.; Xu, C.; Li, X. Bienzymatically crosslinked gelatin/hyaluronic acid interpenetrating network hydrogels: Preparation and characterization. RSC Adv. 2015, 5, 1929–1936. [Google Scholar] [CrossRef]
- Naseri, N.; Deepa, B.; Mathew, A.P.; Oksman, K.; Girandon, L. Nanocellulose-Based Interpenetrating Polymer Network (IPN) hydrogels for cartilage applications. Biomacromolecules 2016, 17, 3714–3723. [Google Scholar] [CrossRef]
- Matricardi, P.; Di Meo, C.; Coviello, T.; Hennink, W.E.; Alhaique, F. Interpenetrating Polymer Networks polysaccharide hydrogels for drug delivery and tissue engineering. Adv. Drug Deliv. Rev. 2013, 65, 1172–1187. [Google Scholar] [CrossRef]
- Dragan, E.S. Design and applications of interpenetrating polymer network hydrogels. A review. Chem. Eng. J. 2014, 243, 572–590. [Google Scholar] [CrossRef]
- Lee, J.W.; Kim, S.Y.; Kim, S.S.; Lee, Y.M.; Lee, K.H.; Kim, S.J. Synthesis and characteristics of interpenetrating polymer network hydrogel composed of chitosan and poly(acrylic acid). J. Appl. Polym. Sci. 1999, 73, 113–120. [Google Scholar] [CrossRef]
- Wen, C.; Lu, L.; Li, X. Mechanically robust gelatin-alginate IPN hydrogels by a combination of enzymatic and ionic crosslinking approaches. Macromol. Mater. Eng. 2014, 299, 504–513. [Google Scholar] [CrossRef]
- Jin, R.; Lin, C.; Cao, A. Enzyme-mediated fast injectable hydrogels based on chitosan-glycolic acid/tyrosine: Preparation, characterization, and chondrocyte culture. Polym. Chem. 2014, 5, 391–398. [Google Scholar] [CrossRef]
- Liu, J.; Pu, H.; Liu, S.; Kan, J.; Jin, C. Synthesis, characterization, bioactivity and potential application of phenolic acid grafted chitosan: A review. Carbohydr. Polym. 2017, 174, 999–1017. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Wong, C.-W.; Chang, S.-W.; Hsu, S. An injectable, self-healing phenol-functionalized chitosan hydrogel with fast gelling property and visible light-crosslinking capability for 3D printing. Acta Biomater. 2021, 122, 211–219. [Google Scholar] [CrossRef] [PubMed]
- Guo, F.; Li, G.; Zhou, H.; Ma, S.; Guo, L.; Liu, X. Temperature and H2O2-operated nano-valves on mesoporous silica nanoparticles for controlled drug release and kinetics. Colloids Surf. B Biointerfaces 2020, 187, 110643. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Z.; Li, G.; Wang, N.; Guo, F.; Guo, L.; Liu, X. Synthesis of temperature/pH dual-sensitive supramolecular micelles from β-cyclodextrin-poly(N-isopropylacrylamide) star polymer for drug delivery. Colloids Surf. B Biointerfaces 2018, 172, 136–142. [Google Scholar] [CrossRef]
- Jin, L.; Huang, Q.J.; Zeng, H.Y.; Du, J.Z.; Xu, S.; Chen, C.R. Hydrotalcite-gated hollow mesoporous silica delivery system for controlled drug release. Microporous Mesoporous Mater. 2019, 274, 304–312. [Google Scholar] [CrossRef]
- Perioli, L.; Posati, T.; Nocchetti, M.; Bellezza, F.; Costantino, U.; Cipiciani, A. Intercalation and release of antiinflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound. Appl. Clay Sci. 2011, 53, 374–378. [Google Scholar] [CrossRef]
- Tan, D.; Yuan, P.; Annabi-Bergaya, F.; Liu, D.; Wang, L.; Liu, H.; He, H. Loading and in vitro release of ibuprofen in tubular halloysite. Appl. Clay Sci. 2014, 96, 50–55. [Google Scholar] [CrossRef]
- Kong, B.J.; Kim, A.; Park, S.N. Properties and in vitro drug release of hyaluronic acid-hydroxyethyl cellulose hydrogels for transdermal delivery of isoliquiritigenin. Carbohydr. Polym. 2016, 147, 473–481. [Google Scholar] [CrossRef] [PubMed]
- Korsmeyer, R.W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15, 25–35. [Google Scholar] [CrossRef]
- Peppas, N.A.; Sahlin, J.J. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 1989, 57, 169–172. [Google Scholar] [CrossRef]
Figure 1.
The MC solution before (a) and after (b) HRP-catalysed crosslinking. The concentrations of MC, HRP, and H2O2 are 10 mg mL−1, 5 U mL−1, and 0.8 mM.
Figure 1.
The MC solution before (a) and after (b) HRP-catalysed crosslinking. The concentrations of MC, HRP, and H2O2 are 10 mg mL−1, 5 U mL−1, and 0.8 mM.
Figure 2.
Hydrodynamic diameter distributions of multiple-crosslinked nanogels prepared with different methods. The concentrations of TPP (a) or Na2MoO4 (b) were 0.05 mg mL−1, respectively.
Figure 2.
Hydrodynamic diameter distributions of multiple-crosslinked nanogels prepared with different methods. The concentrations of TPP (a) or Na2MoO4 (b) were 0.05 mg mL−1, respectively.
Figure 3.
Hydrodynamic diameter distributions of multiple-crosslinked nanogels prepared with the method A and B. The concentrations of TPP or Na2MoO4 were 0.20 (a), 0.10 (b), 0.05 (c), 0.04 (d) mg mL−1, respectively.
Figure 3.
Hydrodynamic diameter distributions of multiple-crosslinked nanogels prepared with the method A and B. The concentrations of TPP or Na2MoO4 were 0.20 (a), 0.10 (b), 0.05 (c), 0.04 (d) mg mL−1, respectively.
Figure 4.
(a) Scheme of 5-FU loading in multiple-crosslinked nanogel; (b) Hydrodynamic diameter distributions of MC/M/H-B4 nanogels with different 5-FU dosages.
Figure 4.
(a) Scheme of 5-FU loading in multiple-crosslinked nanogel; (b) Hydrodynamic diameter distributions of MC/M/H-B4 nanogels with different 5-FU dosages.
Figure 5.
Release profiles of MC/M/H-B4 nanogels (a–c) and the maximum cumulative 5-FU release from nanogels with different drug dosages at different pH values (d).
Figure 5.
Release profiles of MC/M/H-B4 nanogels (a–c) and the maximum cumulative 5-FU release from nanogels with different drug dosages at different pH values (d).
Table 1.
Composition of multiple-crosslinked nanogels with TPP and HRP.
| Sample | MC (mg mL−1) | TPP (mg mL−1) | HRP ((U mL−1) | H2O2 (mM) |
|---|---|---|---|---|
| MC/T/H-A1 | 1.0 | 0.20 | 0.5 | 0.08 |
| MC/T/H-A2 | 1.0 | 0.10 | 0.5 | 0.08 |
| MC/T/H-A3 | 1.0 | 0.05 | 0.5 | 0.08 |
| MC/T/H-A4 | 1.0 | 0.04 | 0.5 | 0.08 |
| MC/T/H-B1 | 1.0 | 0.20 | 0.5 | 0.08 |
| MC/T/H-B2 | 1.0 | 0.10 | 0.5 | 0.08 |
| MC/T/H-B3 | 1.0 | 0.05 | 0.5 | 0.08 |
| MC/T/H-B4 | 1.0 | 0.04 | 0.5 | 0.08 |
A: The crosslinking occurs with TPP first and then with HRP; B: The crosslinking occurs with TPP and HRP simultaneously.
Table 2.
Composition of multiple-crosslinked nanogels with Na2MoO4 and HRP.
| Sample | MC (mg mL−1) | Na2MoO4 (mg mL−1) | HRP (U mL−1) | H2O2 (mM) |
|---|---|---|---|---|
| MC/M/H-A1 | 1.0 | 0.20 | 0.5 | 0.08 |
| MC/M/H-A2 | 1.0 | 0.10 | 0.5 | 0.08 |
| MC/M/H-A3 | 1.0 | 0.05 | 0.5 | 0.08 |
| MC/M/H-A4 | 1.0 | 0.04 | 0.5 | 0.08 |
| MC/M/H-B1 | 1.0 | 0.20 | 0.5 | 0.08 |
| MC/M/H-B2 | 1.0 | 0.10 | 0.5 | 0.08 |
| MC/M/H-B3 | 1.0 | 0.05 | 0.5 | 0.08 |
| MC/M/H-B4 | 1.0 | 0.04 | 0.5 | 0.08 |
A: The crosslinking occurs with Na2MoO4 first and then with HRP; B: The crosslinking occurs with Na2MoO4 and HRP simultaneously.
Table 3.
The drug-loading content and entrapment efficiency of MC/M/H-B4 nanogels for 5-FU (all data are expressed as mean ± SD, n = 10).
Table 3.
The drug-loading content and entrapment efficiency of MC/M/H-B4 nanogels for 5-FU (all data are expressed as mean ± SD, n = 10).
| m0/m (%) | |||
|---|---|---|---|
| 50 | 100 | 150 | |
| DLC (%) | 23.55 ± 4.68 | 32.30 ± 7.04 | 35.01 ± 5.19 |
| EE (%) | 66.82 ± 7.92 | 64.60 ± 4.09 | 58.35 ± 8.66 |
m0 and m are the weight of 5-FU and MC/M/H-B4 nanogels, respectively.
Table 4.
Kinetic parameters of 5-FU release from MC/M/H-B4 nanogels.
| Models | m0/m (%) | pH = 5.5 | pH = 6.5 | pH = 7.5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R2 | R2 | R2 | ||||||||
| Zero-order | 50 | 0.9108 | 0.8786 | 0.9365 | ||||||
| F = kt | 100 | 0.8967 | 0.8655 | 0.7143 | ||||||
| 150 | 0.8902 | 0.7734 | 0.647 | |||||||
| R2 | R2 | R2 | ||||||||
| First-order | 50 | 0.9496 | 0.9081 | 0.9538 | ||||||
| F = 1 − e−kt | 100 | 0.9314 | 0.8881 | 0.7322 | ||||||
| 150 | 0.9077 | 0.7902 | 0.6562 | |||||||
| R2 | R2 | R2 | ||||||||
| Higuchi | 50 | 0.9856 | 0.9647 | 0.9874 | ||||||
| F = kt0.5 | 100 | 0.9768 | 0.9661 | 0.8765 | ||||||
| 150 | 0.982 | 0.9149 | 0.8276 | |||||||
| R2 | n | R2 | n | R2 | n | |||||
| Korsmeyer-Peppas | 50 | 0.9908 | 0.6106 | 0.9798 | 0.6502 | 0.9767 | 0.4823 | |||
| F = ktn | 100 | 0.9849 | 0.4493 | 0.9893 | 0.3026 | 0.9536 | 0.2738 | |||
| 150 | 0.9947 | 0.3302 | 0.9687 | 0.2369 | 0.9444 | 0.2199 | ||||
| R2 | k1 | k2 | R2 | k1 | k2 | R2 | k1 | k2 | ||
| Peppas-Sahlin | 50 | 0.9947 | 0.3034 | −0.0286 | 0.9853 | 0.2361 | −0.0206 | 0.9851 | 0.1933 | −0.0208 |
| F = k1tm + k2t2m | 100 | 0.9717 | 0.3067 | −0.0385 | 0.9809 | 0.1161 | −0.0094 | 0.9764 | 0.1333 | −0.0174 |
| 150 | 0.9901 | 0.1568 | −0.0194 | 0.9542 | 0.0686 | −0.0062 | 0.9565 | 0.0935 | −0.0132 | |
In all models, F is the fraction mass of 5-FU released at time t, and k (or k1, k2) is the kinetic constant.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Tao, Q.; Zhong, J.; Wang, R.; Huang, Y. Ionic and Enzymatic Multiple-Crosslinked Nanogels for Drug Delivery. Polymers 2021, 13, 3565. https://doi.org/10.3390/polym13203565
AMA Style
Tao Q, Zhong J, Wang R, Huang Y. Ionic and Enzymatic Multiple-Crosslinked Nanogels for Drug Delivery. Polymers. 2021; 13(20):3565. https://doi.org/10.3390/polym13203565
Chicago/Turabian StyleTao, Qian, Julong Zhong, Rui Wang, and Yuzhu Huang. 2021. "Ionic and Enzymatic Multiple-Crosslinked Nanogels for Drug Delivery" Polymers 13, no. 20: 3565. https://doi.org/10.3390/polym13203565
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
